144 related articles for article (PubMed ID: 17850766)
1. Requirement for protein kinase R in interleukin-1alpha-stimulated effects in cartilage.
Tam CL; Hofbauer M; Towle CA
Biochem Pharmacol; 2007 Dec; 74(11):1636-41. PubMed ID: 17850766
[TBL] [Abstract][Full Text] [Related]
2. Effect of Phellodendron amurense in protecting human osteoarthritic cartilage and chondrocytes.
Kim JH; Huh JE; Baek YH; Lee JD; Choi DY; Park DS
J Ethnopharmacol; 2011 Mar; 134(2):234-42. PubMed ID: 21182922
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-1 receptor antagonist (IL-1Ra) is more effective in suppressing cytokine-induced catabolism in cartilage-synovium co-culture than in cartilage monoculture.
Mehta S; Akhtar S; Porter RM; Önnerfjord P; Bajpayee AG
Arthritis Res Ther; 2019 Nov; 21(1):238. PubMed ID: 31722745
[TBL] [Abstract][Full Text] [Related]
4. Fibroblast growth factor 2 inhibits induction of aggrecanase activity in human articular cartilage.
Sawaji Y; Hynes J; Vincent T; Saklatvala J
Arthritis Rheum; 2008 Nov; 58(11):3498-509. PubMed ID: 18975307
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of interleukin-1-induced proteoglycan degradation and nitric oxide production in bovine articular cartilage/chondrocyte cultures by the natural product, hymenialdisine.
Badger AM; Cook MN; Swift BA; Newman-Tarr TM; Gowen M; Lark M
J Pharmacol Exp Ther; 1999 Aug; 290(2):587-93. PubMed ID: 10411566
[TBL] [Abstract][Full Text] [Related]
6. Protein kinase R plays a pivotal role in oncostatin M and interleukin-1 signalling in bovine articular cartilage chondrocytes.
Gilbert SJ; Blain EJ; Al-Sabah A; Zhang Y; Duance VC; Mason DJ
Eur Cell Mater; 2012 Jan; 23():41-57. PubMed ID: 22287113
[TBL] [Abstract][Full Text] [Related]
7. Involvement of ERKs, RSK2 and PKR in UVA-induced signal transduction toward phosphorylation of eIF2alpha (Ser(51)).
Zykova TA; Zhu F; Zhang Y; Bode AM; Dong Z
Carcinogenesis; 2007 Jul; 28(7):1543-51. PubMed ID: 17404396
[TBL] [Abstract][Full Text] [Related]
8. Regulation of insulin-like growth factor-binding protein-5 by insulin-like growth factor I and interleukin-1alpha in ovine articular chondrocytes.
Sunic D; McNeil JD; Rayner TE; Andress DL; Belford DA
Endocrinology; 1998 May; 139(5):2356-62. PubMed ID: 9564845
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the degradation of type II collagen and proteoglycan in nasal and articular cartilages induced by interleukin-1 and the selective inhibition of type II collagen cleavage by collagenase.
Billinghurst RC; Wu W; Ionescu M; Reiner A; Dahlberg L; Chen J; van Wart H; Poole AR
Arthritis Rheum; 2000 Mar; 43(3):664-72. PubMed ID: 10728761
[TBL] [Abstract][Full Text] [Related]
10. Differential regulation of proteoglycan 4 metabolism in cartilage by IL-1alpha, IGF-I, and TGF-beta1.
Schmidt TA; Gastelum NS; Han EH; Nugent-Derfus GE; Schumacher BL; Sah RL
Osteoarthritis Cartilage; 2008 Jan; 16(1):90-7. PubMed ID: 17596975
[TBL] [Abstract][Full Text] [Related]
11. Effect of ebselen on IL-1-induced alterations in cartilage metabolism.
Pratta MA; Ackerman NR; Arner EC
Inflamm Res; 1998 Mar; 47(3):115-21. PubMed ID: 9562336
[TBL] [Abstract][Full Text] [Related]
12. Dual effect of platelet lysate on human articular cartilage: a maintenance of chondrogenic potential and a transient proinflammatory activity followed by an inflammation resolution.
Pereira RC; Scaranari M; Benelli R; Strada P; Reis RL; Cancedda R; Gentili C
Tissue Eng Part A; 2013 Jun; 19(11-12):1476-88. PubMed ID: 23360471
[TBL] [Abstract][Full Text] [Related]
13. Differential effects of hyperosmotic challenge on interleukin-1-activated pathways in bovine articular cartilage.
Le D; Hofbauer MA; Towle CA
Arch Biochem Biophys; 2006 Jan; 445(1):1-8. PubMed ID: 16359637
[TBL] [Abstract][Full Text] [Related]
14. Differential effects of SB 242235, a selective p38 mitogen-activated protein kinase inhibitor, on IL-1 treated bovine and human cartilage/chondrocyte cultures.
Badger AM; Roshak AK; Cook MN; Newman-Tarr TM; Swift BA; Carlson K; Connor JR; Lee JC; Gowen M; Lark MW; Kumar S
Osteoarthritis Cartilage; 2000 Nov; 8(6):434-43. PubMed ID: 11069728
[TBL] [Abstract][Full Text] [Related]
15. The double-stranded RNA-activated protein kinase PKR is dispensable for regulation of translation initiation in response to either calcium mobilization from the endoplasmic reticulum or essential amino acid starvation.
Kimball SR; Clemens MJ; Tilleray VJ; Wek RC; Horetsky RL; Jefferson LS
Biochem Biophys Res Commun; 2001 Jan; 280(1):293-300. PubMed ID: 11162513
[TBL] [Abstract][Full Text] [Related]
16. Effects of R and S enantiomers and a racemic mixture of carprofen on the production and release of proteoglycan and prostaglandin E2 from equine chondrocytes and cartilage explants.
Armstrong S; Lees P
Am J Vet Res; 1999 Jan; 60(1):98-104. PubMed ID: 9918155
[TBL] [Abstract][Full Text] [Related]
17. Interleukin 17 induced nitric oxide suppresses matrix synthesis and protects cartilage from matrix breakdown.
Cai L; Suboc P; Hogue DA; Fei DT; Filvaroff EH
J Rheumatol; 2002 Aug; 29(8):1725-36. PubMed ID: 12180737
[TBL] [Abstract][Full Text] [Related]
18. Tumour necrosis factor alpha up-regulates protein kinase R (PKR)-activating protein (PACT) and increases phosphorylation of PKR and eukaryotic initiation factor 2-alpha in articular chondrocytes.
Gilbert SJ; Duance VC; Mason DJ
Biochem Soc Trans; 2002 Nov; 30(Pt 6):886-9. PubMed ID: 12440939
[TBL] [Abstract][Full Text] [Related]
19. Cyclooxygenase 2-dependent prostaglandin E2 modulates cartilage proteoglycan degradation in human osteoarthritis explants.
Hardy MM; Seibert K; Manning PT; Currie MG; Woerner BM; Edwards D; Koki A; Tripp CS
Arthritis Rheum; 2002 Jul; 46(7):1789-803. PubMed ID: 12124863
[TBL] [Abstract][Full Text] [Related]
20. Aurothiomalate inhibits cyclooxygenase 2, matrix metalloproteinase 3, and interleukin-6 expression in chondrocytes by increasing MAPK phosphatase 1 expression and decreasing p38 phosphorylation: MAPK phosphatase 1 as a novel target for antirheumatic drugs.
Nieminen R; Korhonen R; Moilanen T; Clark AR; Moilanen E
Arthritis Rheum; 2010 Jun; 62(6):1650-9. PubMed ID: 20178133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]